Halting the disease progression would lead to great benefits to patients, families and caregivers.
The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.
We are developing an innovative treatment that aims to improve the patients’ quality of life.
BioArctic AB published the company’s Interim Report for the period January – June 2019 on Thursday, July 11, 2019.
